Candida Species, Genotypes and Antifungal Susceptibility of Candida Isolates from Blood Samples of Patients at the Largest Tertiary Care Hospital in Thailand during 1999-2002

Journal of the Medical Association of Thailand

Volumn 87, Issue 1, 2004, Pages 92-99

  Foongladda, Suporn ^a   Petlum, Pornphan ^a   Sakulmaiwatana, Piyaporn ^a   Vanprapar, Niran ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Candida species; Candidemia; Drug Susceptibility; Genotypes

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; ANTIFUNGAL AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD SAMPLING; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CHILD; DRUG SENSITIVITY; FEMALE; FUNGUS ISOLATION; GENOTYPE; HOSPITAL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; SPECIES; THAILAND; CANDIDA; CROSS INFECTION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; FEMALE; GENOTYPE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; THAILAND;

EID: 1542288368     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jone RN, Wenze RP. Nosocomial bloodstream infection in united states hospitals: A three-year analysis. Clin Infect Dis 1999; 29: 23944.
2. Pfaller MA, Jones RN, Doern GV, et al. Blood-stream infections due to Candida species: Sentry Antimicrobial Surveillance Program in North America and Latin America, 1997-1999. Antimicrob Agents Chemother 2000; 44: 747-51.
3. St-Germain G, Laverdiere M, Pelietier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a 2 year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001; 39: 949-53.
4. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidosis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-8.
5. Colombo AL, Nucci M, Salomao R, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diag Microbiol Infect Dis 1999; 34: 281-6.
6. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities results of population-based active surveillance. Clin Infect Dis 1999; 29: 1164-70.
7. Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000; 19: 602-7.
8. Nguyen MH, JE Peacock, Morris AJ. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-23.
9. Pfaller MA, Diekema DJ, Jones N, et al. International Surveillance of bloodstream infection due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, Ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in Sentry Antimicrobial Surveillance Program. J Clin Microbiol 2001; 39: 3254-9.
10. McCullough MJ, Clemonso KV, Stevens DA. Molecular and phenotype characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 1999; 37: 417-21.
11. Tamura M, Watanabe K, Mikami Y, Yazawa K, Nishimura K. Molecular Characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: Analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol 2001; 39: 4309-15.
12. Sullivan D, Coleman D. Minireview C. dubliniensis: Characteristics and identification. J Clin Microbiol 1998; 36: 329-34.
13. th ed. Washington DC: American Society for Microbiology; 1999: 1405-14.
14. Godoy P, Tiraboschi IN, Severo LC, et al. Species distribution and antifungal susceptibility profile of Candida spp bloodstream isolates from Latin American Hospitals. Mem Inst Oswaldo Cruz, Rio de Janeiro 2003; 98: 401-5.
15. Colombo AL, Nucci M, Salomao R, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diag Microbiol Infect Dis 1999; 34: 281-6.
16. Al-Hedaithy SSA. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses 2003; 46: 275-80.
17. Yang CW, Barkham MS, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003; 41: 472-4.
18. Chen YC, Chang SC, Luh KT, Hsieh WC. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother 2003; 52: 71-7.
19. Chakrabarti A, Mohan B, Shrivastava SK, Marak RS, Ghosh A, Ray P. Change in distribution & antifungal susceptibility of Candida species isolated from candidaemia cases in a tertiary care center during 1996-2000. Indian J Med Res 2002; 116: 5-12.
20. Mathews MS, Samuel PR, Suresh M. Emergence of Candida tropicalis as the major cause of fungaemia in India. Mycoses 2001; 44: 278-80.